About Fulgent Pharma
Fulgent Pharma is a company based in Temple City (United States) founded in 2011 was acquired by Fulgent Genetics in November 2022.. The company has 3 employees as of December 31, 2022. Fulgent Pharma has completed 1 acquisition, including Fulgent Genetics. Fulgent Pharma offers products and services including FID-007 and Nanoencapsulation Technology. Fulgent Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Temple City, United States
- Employees 3 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Fulgent Pharma Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
3
as on Dec 31, 2022
- Investments & Acquisitions
-
Acquired by
Fulgent Genetics
(Nov 07, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fulgent Pharma
Fulgent Pharma offers a comprehensive portfolio of products and services, including FID-007 and Nanoencapsulation Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Nanoencapsulated paclitaxel for enhanced cancer treatment efficacy.
Platform to improve safety and effectiveness of anti-cancer drugs.
Funding Insights of Fulgent Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Fulgent Pharma
Fulgent Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Fulgent Genetics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Fulgent Pharma
Fulgent Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Fulgent Genetics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Fulgent Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Fulgent Pharma Comparisons
Competitors of Fulgent Pharma
Fulgent Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Fulgent Pharma
Frequently Asked Questions about Fulgent Pharma
When was Fulgent Pharma founded?
Fulgent Pharma was founded in 2011.
Where is Fulgent Pharma located?
Fulgent Pharma is headquartered in Temple City, United States. It is registered at Temple City, California, United States.
How many employees does Fulgent Pharma have?
As of Dec 31, 2022, the latest employee count at Fulgent Pharma is 3.
What does Fulgent Pharma do?
Fulgent Pharma was founded in 2011 and is based in Temple City, United States. Operations focus on the pharmaceutical sector, where anti-cancer drugs are enhanced through patented nanoencapsulation methods. The lead product, FID-007, involves nano-encapsulated paclitaxel and is undergoing clinical trials to improve efficacy while reducing toxicity. Established and novel anti-cancer agents are combined for targeted delivery and lower side effects.
Who are the top competitors of Fulgent Pharma?
Fulgent Pharma's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Fulgent Pharma offer?
Fulgent Pharma offers FID-007 and Nanoencapsulation Technology.
How many acquisitions has Fulgent Pharma made?
Fulgent Pharma has made 1 acquisition, including Fulgent Genetics.
Who are Fulgent Pharma's investors?
Fulgent Pharma has 1 investor. Key investors include Fulgent Genetics.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.